Drugs / RO7121932
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05704361 | Aug 2021 → Jul 2027 expected | multiple sclerosis | Hoffmann-La Roche | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7121932 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05704361 ↗ |
| Route | Intravenous | “as an IV infusion” NCT05704361 ↗ |